Federation des caisses Desjardins du Quebec’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.67M | Buy |
|
|||||
|
2025
Q2 | $2.46M | Sell |
|
|||||
|
2025
Q1 | $2.55M | Buy |
|
|||||
|
2024
Q4 | $2.13M | Sell |
|
|||||
|
2024
Q3 | $5.17M | Buy |
|
|||||
|
2024
Q2 | $3.88M | Sell |
|
|||||
|
2024
Q1 | $3.17M | Buy |
|
|||||
|
2023
Q4 | $3.07M | Hold |
|
|||||
|
2023
Q3 | $2.84M | Sell |
|
|||||
|
2023
Q2 | $3.27M | Sell |
|
|||||
|
2023
Q1 | $5.46M | Sell |
|
|||||
|
2022
Q4 | $8.01M | Hold |
|
|||||
|
2022
Q3 | $6.75M | Sell |
|
|||||
|
2022
Q2 | $5.03M | Buy |
|
|||||
|
2022
Q1 | $5.48M | Buy |
|
|||||
|
2021
Q4 | $5.5M | Sell |
|
|||||
|
2021
Q3 | $6.42M | Sell |
|
|||||
|
2021
Q2 | $6.03M | Sell |
|
|||||
|
2021
Q1 | $5.13M | Sell |
|
|||||
|
2020
Q4 | $6.06M | Sell |
|
|||||
|
2020
Q3 | $7.55M | Sell |
|
|||||
|
2020
Q2 | $8.34M | Sell |
|
|||||
|
2020
Q1 | $6.55M | Hold |
|
|||||
|
2019
Q4 | $6.84M | Buy |
|
|||||
|
2019
Q3 | $4.52M | Buy |
|
|||||
|
2019
Q2 | $2.24M | Hold |
|
|||||
|
2019
Q1 | $2.89M | Buy |
|
|||||
|
2018
Q4 | $1.7M | Hold |
|
|||||
|
2018
Q3 | $2.04M | Hold |
|
|||||
|
2018
Q2 | $2.3M | Hold |
|
|||||
|
2018
Q1 | $2.77M | Hold |
|
|||||
|
2017
Q4 | $2.95M | Hold |
|
|||||
|
2017
Q3 | $2.74M | Hold |
|
|||||
|
2017
Q2 | $1.86M | Sell |
|
|||||
|
2017
Q1 | $1.37M | Buy |
|